PureCycle (PCT) Form 3: Director holds 300 Series B; $14.02
PureCycle Technologies (PCT) director Siri Jirapongphan filed a Form 3 initial beneficial ownership statement.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PureCycle Technologies (PCT) director Siri Jirapongphan filed a Form 3 initial beneficial ownership statement. The filing lists Series B Convertible Perpetual Preferred Stock with a $14.02 conversion price and notes the security is perpetual with no expiration.
The explanation states Dr. Jirapongphan purchased 300 shares of Series B at $1,000 per share for an aggregate $300,000. The Series B is convertible into common stock at a rate equal to the sum of $1,000 plus in‑kind and accrued dividends divided by the conversion price. The table reflects a date exercisable of 06/20/2025 and direct ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Series B Convertible Perpetual Preferred Stock | -- | -- | -- |
Footnotes (2)
- F1. The Series B Convertible Perpetual Preferred Stock is perpetual and therefore has no expiration date.
- F2. Dr. Jirapongphan purchased 300 shares of the Series B securities at an initial issue price of $1,000 per share, for an aggregate purchase price of $300,000. The Series B Convertible Perpetual Preferred Stock is convertible into shares of Common Stock of the issuer at a conversion rate equal to (a) the sum of $1,000 plus in kind dividends plus accrued dividends divided by (b) the conversion price.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PureCycle (PCT) disclose in this filing?
What security does the PCT director beneficially own?
What is the conversion price for the Series B into common stock?
How is the conversion rate determined?
Does the Series B have an expiration date?
What key dates are included?
AI-generated analysis. How Rhea-AI works. Not financial advice.